Incidence rates among women 50 to 64 have now surpassed those of men, while cancer rates for females under 50 are 82% higher than their male counterparts, the ACS reports. 

The President made good on a campaign promise to leave the international health agency, after attempting to do so when he last held office in 2020. 

Walgreens filed a countersuit, accusing the federal government of failing to take down prescribers acting unlawfully. 

Intravascular lithotripsy has quickly emerged as one of healthcare’s most in-demand technologies. Now Shockwave Medical, part of Johnson & Johnson MedTech, is co-hosting a webinar designed to teach coding and billing specialists how to code appropriately for peripheral and coronary IVL procedures. 

Alignment Health is accusing CMS and a third-party contractor of surveying Spanish-speaking members in English and using an "arbitrary" calculation method to reduce the ratings of Medicare Advantage plans.

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated. 

The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.